Literature DB >> 21866364

Is there a role for measuring central aortic pressure?

Yonghong Huan1, Raymond Townsend.   

Abstract

Peripheral brachial blood pressure measurements by sphygmomanometry remains the standard for measuring and managing blood pressure. Elevated brachial blood pressure is a major risk for cardiovascular disease, and reduction of bracial blood pressure decreases target organ damage and cardiovascular events. However, many patients still succumb to heart disease, stroke, kidney failure, and death even when the brachial blood pressures appear adequately controlled. Central aortic pressure may be more relevant to the pathogenesis of cardiovascular disease, which is not always accurately represented by brachial blood pressure. Noninvasive applanation tonometry can now assess central aortic pressure easily and reliably. Emerging data suggest that central arotic pressure and related parameters are often better and more robust predictors of cardiovascular outcome than peripheral brachial blood pressures.

Entities:  

Mesh:

Year:  2011        PMID: 21866364     DOI: 10.1007/s11886-011-0214-1

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  27 in total

1.  The paradigm has shifted, to systolic blood pressure.

Authors:  H R Black
Journal:  Hypertension       Date:  1999-09       Impact factor: 10.190

2.  Brachial blood pressure but not carotid arterial waveforms predict cardiovascular events in elderly female hypertensives.

Authors:  Anthony M Dart; Christoph D Gatzka; Bronwyn A Kingwell; Kristyn Willson; James D Cameron; Yu-Lu Liang; Karen L Berry; Lindon M H Wing; Christopher M Reid; Philip Ryan; Lawrence J Beilin; Garry L R Jennings; Colin I Johnston; John J McNeil; Graham J Macdonald; Trefor O Morgan; Malcolm J West
Journal:  Hypertension       Date:  2006-02-27       Impact factor: 10.190

3.  Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Authors:  Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristiansson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Journal:  Lancet       Date:  2002-03-23       Impact factor: 79.321

4.  Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Authors:  Lars H Lindholm; Hans Ibsen; Björn Dahlöf; Richard B Devereux; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Krister Kristiansson; Ole Lederballe-Pedersen; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel; Peter Aurup; Jonathan Edelman; Steven Snapinn
Journal:  Lancet       Date:  2002-03-23       Impact factor: 79.321

5.  Central pulse pressure and mortality in end-stage renal disease.

Authors:  Michel E Safar; Jacques Blacher; Bruno Pannier; Alain P Guerin; Sylvain J Marchais; Pierre-Marie Guyonvarc'h; Gérard M London
Journal:  Hypertension       Date:  2002-03-01       Impact factor: 10.190

6.  Central but not brachial blood pressure predicts cardiovascular events in an unselected geriatric population: the ICARe Dicomano Study.

Authors:  Riccardo Pini; M Chiara Cavallini; Vittorio Palmieri; Niccolò Marchionni; Mauro Di Bari; Richard B Devereux; Giulio Masotti; Mary J Roman
Journal:  J Am Coll Cardiol       Date:  2008-06-24       Impact factor: 24.094

7.  Arterial stiffness and cardiovascular events: the Framingham Heart Study.

Authors:  Gary F Mitchell; Shih-Jen Hwang; Ramachandran S Vasan; Martin G Larson; Michael J Pencina; Naomi M Hamburg; Joseph A Vita; Daniel Levy; Emelia J Benjamin
Journal:  Circulation       Date:  2010-01-18       Impact factor: 29.690

8.  Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study.

Authors:  Gary F Mitchell; Helen Parise; Emelia J Benjamin; Martin G Larson; Michelle J Keyes; Joseph A Vita; Ramachandran S Vasan; Daniel Levy
Journal:  Hypertension       Date:  2004-05-03       Impact factor: 10.190

9.  Superior effect of an angiotensin-converting enzyme inhibitor over a diuretic for reducing aortic systolic pressure.

Authors:  Xiong-Jing Jiang; Michael F O'Rourke; Yu-Qing Zhang; Xin-Ye He; Li-Sheng Liu
Journal:  J Hypertens       Date:  2007-05       Impact factor: 4.844

10.  Pulsatile but not steady component of blood pressure predicts cardiovascular events in coronary patients.

Authors:  Piotr Jankowski; Kalina Kawecka-Jaszcz; Danuta Czarnecka; Malgorzata Brzozowska-Kiszka; Katarzyna Styczkiewicz; Magdalena Loster; Małgorzata Kloch-Badełek; Jerzy Wiliński; Adam M Curyło; Dariusz Dudek
Journal:  Hypertension       Date:  2008-02-11       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.